Developments in the Field of Medical Devices
Gün + Partners , Co-Author ,
Aug 14, 2024
Interactions with HCPs, Transfer of Values and Payments
Gün + Partners , Co-Author ,
Aug 14, 2024
Named Patient Program
Gün + Partners , Co-Author ,
Aug 14, 2024
Market Access- Alternative Reimbursement Models
Gün + Partners , Co-Author ,
Aug 14, 2024
Pricing of Pharmaceuticals and the Fixed Exchange Rate
Gün + Partners , Co-Author ,
Aug 14, 2024
Guideline on Medicine Priority Assessment Has Been Updated
Gün + Partners , Co-Author ,
Jun 20, 2024
Guideline on Co-Marketing of Medicines has been Updated
Gün + Partners , Co-Author ,
Jun 20, 2024
What Will be The Fate of The Guarantee Provided For The Preliminary Injunction Decision?
ManagingIP , Co-Author ,
Jun 13, 2024
Türkiye’s Update: Key Changes in Named Patient Program
LIR Turkiye Edition 5 N°2 , Co-Author ,
Jun 07, 2024
EU Pharmaceutical Package - EU Pharmaceutical Legislative Reform and its Impact on Türkiye
Gün + Partners , Co-Author ,
Jun 03, 2024
Türkiye's Update: Key Changes in Named Patient Program
Legal Industries Review Türkiye Edition 5 N°2 , Co-Author ,
May 21, 2024
Turkish Medicines and Medical Devices Agency Published the Industry Report on Medical Devices
Gün + Partners , Co-Author ,
Apr 22, 2024
Named Patient Program in Turkey
Biolegis , Co-Author ,
Mar 18, 2024
Türkiye's Update: Key Changes in Named Patient Program
Gün + Partners , Co-Author ,
Dec 18, 2023
Healthcare Regulation 2024 in Turkey
GTDT , Co-Author ,
Oct 02, 2023
